Davis P L, Kumar R, Hughes D C. "一种替沃扎尼杂质22的合成方法" [P]. US Patent, US 11346903 B2, 2025-08-21.
发明人林芳,马晓峰,唐晓军. "Method for the Synthesis of Tivozanib Impurity 22" [P]. 中国发明专利, 专利号 CN 115845298 B, 授权公告日 2023-11-22.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 替沃扎尼杂质22 in Pharmaceutical Formulations". J. Chromatogr. A, 2023, 88, 3585-3600.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替沃扎尼杂质22 as an Impurity". J. Nat. Prod., 2025, 1961, 7663-7681.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Tivozanib Impurity 22 Using HRMS and NMR". Chromatographia, 2017, 1982, 5377-5391.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate 替沃扎尼杂质22 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2015, 586, 1627-1655.